Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 151 to 175 of 2564

TitleReference numberPublishedLast updated
Sacituzumab govitecan for treating hormone receptor-positive HER2-negative metastatic breast cancer after 2 or more treatments (terminated appraisal)TA1089
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceTA1086
Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollenTA1087
Overweight and obesity managementQS212
Single-step scaffold insertion for repairing symptomatic chondral knee defectsHTG728
Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overTA1085
Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessmentHTG756
Cenobamate for treating focal onset seizures in epilepsyTA753
Cardiovascular risk assessment and lipid modificationQS100
Letermovir for preventing cytomegalovirus infection after a kidney transplant (terminated appraisal)TA1082
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)TA1083
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 treatments (terminated appraisal)TA1084
Fruquintinib for previously treated metastatic colorectal cancerTA1079
One-piece closed bags for colostomies: late-stage assessmentHTG754
Mirikizumab for previously treated moderately to severely active Crohn's diseaseTA1080
Zanubrutinib for treating relapsed or refractory mantle cell lymphomaTA1081
Pulsed-field ablation for atrial fibrillationHTG755
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessmentHTG753
Dapagliflozin for treating chronic kidney diseaseTA1075
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)TA1076
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and overTA1077
Fosdenopterin for treating molybdenum cofactor deficiency type A (terminated appraisal)TA1078
Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitationHTG752
Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodiesTA1073
Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessmentHTG751

Results per page

  1. 10
  2. 25
  3. 50
  4. All